James Manuso
@jamesmanuso2481
Director
Building Ocuphire Pharma, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Ocuphire Pharma, Inc. was founded in 2018 and has no closure on record.
Named alongside
- Alan ListDirector
- Dan DearbornExecutive Officer
- Daniel DearbornExecutive Officer
- Dan John DearbornExecutive Officer
- David John BergmannDirector
- David John LawmanDirector
- George C. NgDirector
- George NgDirector
- Alan MeyerDirector
- Bernhard HoffmannExecutive Officer
- Cam GallagherDirector
- Meyer AlanDirector
- Mina SoochExecutive Officer, Director
- Sean AinsworthDirector
- Alan R. MeyerDirector
- Amy J. Zaremba RabournExecutive Officer
- Amy RabournExecutive Officer
- Ash JayagopalExecutive Officer
- Bernhard HoffmannExecutive Officer
- Bernhard J. HoffmannExecutive Officer
- Cam GallagherDirector
- Cam S. GallagherDirector
At TuHURA Biosciences, Inc./NV
- Alan ListDirector
- Craig TendlerDirector
- Dan DearbornExecutive Officer
- Dennis BrownExecutive Officer, Director
- Erich K MohrDirector
- George NgDirector
Contribution
James's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Ocuphire Pharma, Inc.Director · Biotechnology · WEST BLOOMFIELD, United States · Founded 2018
- MORPHOGENESIS INCPharmaceutical Preparations; formerly MORPHOGENESIS INC; filing with the SEC since 2003Director · Biotechnology · TAMPA, United States
- Ocuphire Pharma, Inc.Pharmaceutical Preparations; formerly Ocuphire Pharma, Inc.; listed on Nasdaq as IRD; filing with the SEC since 2005Director · Biotechnology · FARMINGTON HILLS, United States
- TuHURA Biosciences, Inc./NVPharmaceutical Preparations; formerly Kintara Therapeutics, Inc.; listed on Nasdaq as HURA; filing with the SEC since 2010Director · Biotechnology · TAMPA, United States